Multiple Myeloma: Epidemiology Trends, Regulations And Competitive Landscape Outlook to 2027: Major Markets - US, France, Germany, Italy, Spain, UK, Japan, and China

The report, titled “Multiple Myeloma: Epidemiology Forecast to 2027,” gives a thorough account of the present state of the global Multiple Myeloma market and the industry concerning it. The report presents an expansive account of the crucial elements of the market, the macro and micro factors that are essential for companies to gain competitive advantage in the market, the key factors that will have the most significant influence on the growth trajectory of the market, and several other aspects of the Multiple Myeloma market from a regional as well as a global perspective.

Download Exclusive Free Sample Of This Report: https://www.researchmoz.us/enquiry.php?type=S&repid=2280128

Multiple myeloma (MM) (International Statistical Classification of Diseases and Related Health Problems, 10th Revision [ICD-10] code = C90.0) is a hematologic cancer that forms in a type of white blood cell called a plasma cell.

In 2017, the 8MM had 81,380 diagnosed incident cases of MM. This is expected to increase to 103,272 diagnosed incident cases by 2027, at an Annual Growth Rate (AGR) of 2.69%. The increase is driven by the aging population in the 8MM. In 2017, the 8MM had 353,890 diagnosed prevalent cases of MM. This is expected to increase to 555,243 diagnosed prevalent cases by 2027, at an AGR of 5.69%. The US had the highest number of diagnosed incident and diagnosed prevalent cases of MM. The development of more effective therapies, particularly for elderly patients, would improve survival and increase disease prevalence.

GlobalDatas epidemiological forecast for the diagnosed incident cases of MM in the 8MM is supported by country-specific data for the age- and sex-specific diagnosed incidence of MM. Additionally, GlobalData adjusted the forecast to account for coding changes in MM diagnosis after 2014. The use of a consistent methodology across the 8MM to forecast the diagnosed incident cases and the diagnosed prevalent cases of MM allows for a meaningful comparison of the forecast incident cases and the forecast prevalent cases of MM in these markets.

Scope

The Multiple Myeloma Epidemiology Report provides an overview of the risk factors and global trends of multiple myeloma in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and China (Urban)). This report also includes a 10-year epidemiological forecast for the following segmentations -
- Diagnosed incident cases of MM
- Diagnosed prevalent cases of MM
- Diagnosed incident cases of MM by symptom status
- Diagnosed incident cases by stem cell transplantation (SCT) eligibility
- Diagnosed incident cases by high-risk cytogenetics (chromosomal abnormalities): t(4;14), t(14;16), t(14;20), and del(17/17p)
- Diagnosed incident cases by revised-international staging system (R-ISS) staging
- The multiple myeloma epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.

Contact For Any Query or to Get Customized Report: https://www.researchmoz.us/enquiry.php?type=E&repid=2280128

Reasons to buy

The Multiple Myeloma Epidemiology report will allow you to -
- Develop business strategies by understanding the trends shaping and driving the global multiple myeloma market.
- Quantify patient populations in the global multiple myeloma market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for multiple myeloma therapeutics in each of the markets covered.
- Understand magnitude of multiple myeloma patient population by risk, SCT eligibility, and R-ISS stages.

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

ResearchMoz
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ https://www.researchmoz.us/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
For More Reports Visit @ http://marketresearchlatestreports.blogspot.com/

This release was published on openPR.